Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease
{{output}}
Background: Although antithyroid drugs (ATDs) are widely used as the first-line therapy for Graves' disease, relapse after treatment discontinuation remains common. While a prolonged low-dose ATD therapy has been associated with... ...
